c-LEcta Grows Significantly in Fiscal Year 2019, Strong Start In 2020
(WorldNews Business)

LEIPZIG, Germany--(BUSINESS WIRE)--Jun 16, 2020-- c-LEcta, a global biotechnology company with technology leadership in enzyme engineering and bioprocess development, successfully concludes 2019 and looks confidently to 2020 after a strong first quarter. The successful development of both the product business and the development partnerships resulted in a 114% increase in revenues in 2019 compared to the previous year to currently EUR 9.1 million (2018: EUR 4.2 million). Total revenues including inventory increases of finished goods and own work capitalized amounted to EUR 9.6 million (2018: EUR 4.5 million). The company thus again grew significantly in 2019 and even exceeded its already...